Evidence map›Paper›PMID 25111785›Full record

ArticlePloS one2014

Common and rare variant analysis in early-onset bipolar disorder vulnerability.

Stéphane Jamain, Sven Cichon, Bruno Etain, Thomas W Mühleisen, Alexander Georgi, Nora Zidane, Lucie Chevallier, Jasmine Deshommes, Aude Nicolas, Annabelle Henrion and 22 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Characterisation of age and polarity at onset in bipolar disorder.The British journal of psychiatry : the journal of mental science · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Reduced Expression ofFrontiers in endocrinology · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Stéphane JamainInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Sven CichonInstitute of Neuroscience and Medicine (INM-1), Research Center Juelich, Juelich, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany; Division of Medical Genetics, University Hospital and Department of Biomedicine, University of Basel, Basel, Switzerland.
Bruno EtainInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor-Albert Chenevier, Pôle de Psychiatry, Créteil, France.
Thomas W MühleisenInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
Alexander GeorgiDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, University of Bonn, Bonn, Germany.
Nora ZidaneInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Lucie ChevallierInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Jasmine DeshommesInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor-Albert Chenevier, Plate-forme de Resources Biologiques, Créteil, France; Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 006, Hôpital Henri Mondor-Albert Chenevier, Pôle Recherche Clinique Santé Publique, Créteil, France.
Aude NicolasInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Annabelle HenrionInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Franziska DegenhardtInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
Manuel MattheisenInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany; Department of Biomedicine and the Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark.
Lutz PriebeInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
Flavie MathieuInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France.
Jean-Pierre KahnFondation FondaMental, Créteil, France; Département de Psychiatrie et de Psychologie Clinique, Centre Hospitalier Universitaire de Nancy, Hôpital Jeanne-d'Arc, Toul, France.
Chantal HenryInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor-Albert Chenevier, Pôle de Psychiatry, Créteil, France.
Anne BolandCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Diana ZelenikaCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Ivo GutCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Simon HeathCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Mark LathropCommissariat à l'Energie Atomique, Institut Génomique, Centre National de Génotypage, Evry, France.
Wolfgang MaierDepartment of Psychiatry, University of Bonn, Bonn, Germany.
Margot AlbusDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany.
Marcella RietschelDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry, University of Bonn, Bonn, Germany.
Thomas G SchulzeDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Mannheim, Germany; Department of Psychiatry and Psychotherapy, University Medical Center, Georg-August-Universität, Göttingen, Germany.
Francis J McMahonUnit on the Genetic Basis of Mood and Anxiety Disorders, National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, United States of America.
John R KelsoeDepartment of Psychiatry, University of California San Diego, La Jolla, CA, United States of America.
Marian HamshereMRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom.
Nicholas CraddockMRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Heath Park, Cardiff, United Kingdom.
Markus M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany.
Frank BellivierInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Fondation FondaMental, Créteil, France; Assistance Publique - Hôpitaux de Paris, Groupe Hospitalier Lariboisière-F. Widal, Pôle de Psychiatrie, Paris, France; Université Paris Diderot, Paris, France.
Marion LeboyerInstitut National de la Santé et de la Recherche Médicale U955, Psychiatrie Génétique, Créteil, France; Université Paris-Est, Faculté de Médecine, Créteil, France; Fondation FondaMental, Créteil, France; Assistance Publique - Hôpitaux de Paris, Hôpital Henri Mondor-Albert Chenevier, Pôle de Psychiatry, Créteil, France.

Funding

Identification of Genes Involved in Major Mood DisordersZIAMH002843 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$24.5M
Wellcome Trust
6 · The paper itself

Abstract

Bipolar disorder is one of the most common and devastating psychiatric disorders whose mechanisms remain largely unknown. Despite a strong genetic contribution demonstrated by twin and adoption studies, a polygenic background influences this multifactorial and heterogeneous psychiatric disorder. To identify susceptibility genes on a severe and more familial sub-form of the disease, we conducted a genome-wide association study focused on 211 patients of French origin with an early age at onset and 1,719 controls, and then replicated our data on a German sample of 159 patients with early-onset bipolar disorder and 998 controls. Replication study and subsequent meta-analysis revealed two genes encoding proteins involved in phosphoinositide signalling pathway (PLEKHA5 and PLCXD3). We performed additional replication studies in two datasets from the WTCCC (764 patients and 2,938 controls) and the GAIN-TGen cohorts (1,524 patients and 1,436 controls) and found nominal P-values both in the PLCXD3 and PLEKHA5 loci with the WTCCC sample. In addition, we identified in the French cohort one affected individual with a deletion at the PLCXD3 locus and another one carrying a missense variation in PLCXD3 (p.R93H), both supporting a role of the phosphatidylinositol pathway in early-onset bipolar disorder vulnerability. Although the current nominally significant findings should be interpreted with caution and need replication in independent cohorts, this study supports the strategy to combine genetic approaches to determine the molecular mechanisms underlying bipolar disorder.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideAge of OnsetBipolar DisorderCohort StudiesFemaleGenetic Predisposition to DiseaseHumansMaleWhite PeopleYoung Adult

Identifiers

PMID25111785
PMCPMC4128749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.